PNC Financial Services Group’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-220
| Closed | -$354 | – | 4914 |
|
2025
Q1 | $354 | Buy |
+220
| New | +$354 | ﹤0.01% | 4699 |
|
2024
Q2 | – | Sell |
-100
| Closed | -$783 | – | 4762 |
|
2024
Q1 | $783 | Buy |
+100
| New | +$783 | ﹤0.01% | 4421 |
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$9.45K | – | 4733 |
|
2023
Q1 | $9.45K | Buy |
+1,000
| New | +$9.45K | ﹤0.01% | 3833 |
|
2021
Q1 | – | Sell |
-6,616
| Closed | -$52K | – | 4104 |
|
2020
Q4 | $52K | Hold |
6,616
| – | – | ﹤0.01% | 2869 |
|
2020
Q3 | $64K | Hold |
6,616
| – | – | ﹤0.01% | 2579 |
|
2020
Q2 | $70K | Hold |
6,616
| – | – | ﹤0.01% | 2559 |
|
2020
Q1 | $38K | Sell |
6,616
-27,758
| -81% | -$159K | ﹤0.01% | 2782 |
|
2019
Q4 | $225K | Hold |
34,374
| – | – | ﹤0.01% | 1991 |
|
2019
Q3 | $237K | Hold |
34,374
| – | – | ﹤0.01% | 2039 |
|
2019
Q2 | $254K | Hold |
34,374
| – | – | ﹤0.01% | 2027 |
|
2019
Q1 | $494K | Hold |
34,374
| – | – | ﹤0.01% | 1642 |
|
2018
Q4 | $399K | Buy |
34,374
+6,616
| +24% | +$76.8K | ﹤0.01% | 1670 |
|
2018
Q3 | $617K | Buy |
+27,758
| New | +$617K | ﹤0.01% | 1564 |
|